Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis
出版年份 2019 全文链接
标题
Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis
作者
关键词
-
出版物
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-19
DOI
10.1007/s10557-019-06910-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness and Safety of Four Direct Oral Anticoagulants in Asians with Non-valvular Atrial Fibrillation
- (2019) Yi-Hsin Chan et al. CHEST
- Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data
- (2018) Shun Kohsaka et al. CURRENT MEDICAL RESEARCH AND OPINION
- Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation
- (2018) Christina Ji-Young Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
- (2018) Yi‐Hsin Chan et al. Journal of the American Heart Association
- Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation
- (2018) Hee Tae Yu et al. STROKE
- Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis
- (2018) Yukihiro Koretsune et al. Journal of Cardiology
- Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation
- (2017) Ki Hong Lee et al. EUROPACE
- Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin
- (2017) W. C. Y. Lau et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation
- (2017) George Ntaios et al. STROKE
- Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
- (2017) Myung-Jin Cha et al. STROKE
- Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
- (2017) Ying Bai et al. STROKE
- Stroke prevention in atrial fibrillation: Past, present and future
- (2017) Ben Freedman et al. THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
- (2016) Wen-Hua Li et al. CLINICAL CARDIOLOGY
- Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
- (2016) Pak-Hei Chan et al. HEART RHYTHM
- Stroke prevention in atrial fibrillation
- (2016) Ben Freedman et al. LANCET
- Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
- (2015) Gregory Y.H. Lip et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation
- (2015) Kang-Ling Wang et al. STROKE
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in Chinese patients with atrial fibrillation
- (2013) Lizheng Mao et al. Vascular
- Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial
- (2013) Daniel E. Singer et al. Journal of the American Heart Association
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong
- (2012) Jason C. S. Ho et al. CLINICAL CARDIOLOGY
- Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients
- (2011) B. Weijs et al. EUROPEAN HEART JOURNAL
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started